Anavex Life Sciences Corp.AVXLNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank27
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-39.99M
↓ 12% vs avg
Percentile
P27
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-35.58M
Historical baseline
PeriodValueYoY Change
TTM$-39.99M+13.8%
2025$-46.38M-7.8%
2024$-43.00M+7.6%
2023$-46.54M+2.3%
2022$-47.62M-26.5%
2021$-37.64M-21.2%
2020$-31.06M-7.6%
2019$-28.88M-50.9%
2018$-19.13M-22.9%
2017$-15.57M-